HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for hydrochlorothiazide; labetalol hydrochloride and what is the scope of patent protection?
Hydrochlorothiazide; labetalol hydrochloride
is the generic ingredient in two branded drugs marketed by Schering and Glaxosmithkline, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Clinical Trials: | 1 |
DailyMed Link: | HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
VA Office of Research and Development | |
US Department of Veterans Affairs |
See all HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE clinical trials